Bdr Pharmaceuticals International Private Limited, a active private limited company, was established on 24 September 2002 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230MH2002PTC137329. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.12 Cr and a paid-up capital of ₹5.40 M.
It upholds a compliant status. Employing 1,437 professional, Its leadership includes Aravind Manappa Badiger (Director), Jayesh Shantilal Trivedi (Director), Tejash Vijay Shah (Director). Past directors included Jayesh Shantilal Trivedi, Dharmesh Mahendra Shah, Suresh Chhabildas Shah. It holds no open charges and ₹9.00 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 407-408, Sharda Chambers, New Marine Lines,, Mumbai, Maharashtra, 400020.
U24230MH2002PTC137329
137329
24 September 2002
₹1.12 Cr
₹5.40 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Bdr Pharmaceuticals International Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Aravind Manappa Badiger | Director | 15 Dec 2012 | Current |
| Jayesh Shantilal Trivedi | Director | 04 Dec 2020 | Current |
| Tejash Vijay Shah | Director | 16 Jan 2008 | Current |
| Dharmesh Mahendra Shah | Director | 13 May 2022 | Current |
| Manish Gaur | Nominee Director | 12 May 2022 | Current |
| Raheel Dharmesh Shah | Director | 27 Jul 2011 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 31 Dec 2020 | Past |
| Pramod Abcsdd | Director | 02 Apr 2020 | Past |
| Pramod Abcsdd | Director | 27 Jul 2011 | Past |
| Pramod Abcsdd | Director | 27 Nov 2020 | Past |
| Pramod Abcsdd | Director | 12 May 2022 | Past |
| Pramod Abcsdd | Director | 10 May 2008 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Bdr Pharmaceuticals International Private Limited, for the financial year ended 2025, experienced modest growth in revenue, with a 1% increase. The company also saw a slight improvement in profitability, with a 8.49% increase in profit. The company's net worth Soared by an impressive increase of 11.79%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Bdr Pharmaceuticals International had a promoter holding of 89.83% and a public holding of 10.18%. The company had 6 Subsidiaries and 1 Associate company. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹90,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Mar 2006 | Abn Amro Bank N. V. | ₹9.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Bdr Pharmaceuticals International has a workforce of 1437 employees as of Dec 30, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Bdr Pharmaceuticals International, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bdr Pharmaceuticals International's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Nilam Maulik Vyas was appointed as a Company Secretary was appointed as a Company Secretary on 05 Dec 2025 & has been associated with this company since 1 month 8 days . was recorded as a recent event.
Progress on Bdr Pharmaceuticals International Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
Bdr Pharmaceuticals International Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.
Progress on Anand Kailash Bagaria was appointed as a Cfo was appointed as a Cfo on 10 Jan 2024 & has been associated with this company since 2 years 4 days . was documented.
The activity Dharmesh Mahendra Shah was appointed as a Director was appointed as a Director on 13 May 2022 & has been associated with this company since 3 years 8 months . was completed.
Progress on Manish Gaur was appointed as a Nominee Director was appointed as a Nominee Director on 12 May 2022 & has been associated with this company since 3 years 8 months . was documented.
When you have prostate cancer but don't want to deal with nausea from meds, try BDENZA oral solution. It's gentle on the stomach, sugar-free, and tastes good. Plus, it's only one small serving instead of lots of pills. Doctors can adjust the dose for each patient and it's affordable. BDR Pharma is changing the game with this patient-friendly solution..
When you need to fight off those pesky gram-negative infections, just remember XAVITAZ - a powerful combo of 2g Ceftazidime & 500mg Avibactam. Brought to you by BDR Pharmaceuticals to make sure everyone has access to top-notch treatment. Let's keep those R&D efforts going and help people stay healthy! #XAVITAZ #BDRPharma #GramNegativeInfections #PowerCombo.
The CIN of Bdr Pharmaceuticals International Private Limited is U24230MH2002PTC137329.
Bdr Pharmaceuticals International Private Limited is headquartered at 407-408, Sharda Chambers, New Marine Lines,, Mumbai, Maharashtra, 400020.
Bdr Pharmaceuticals International Private Limited was incorporated on 24 September 2002.
The current directors of Bdr Pharmaceuticals International Private Limited are
The primary industry of Bdr Pharmaceuticals International Private Limited is Manufacturing.
Bdr Pharmaceuticals International Private Limited is unlisted.
The authorized capital of Bdr Pharmaceuticals International Private Limited is ₹1.12 Cr, and the paid-up capital is ₹5.40 M.
The compliance status of Bdr Pharmaceuticals International Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX